IL10 and glioblastoma: In addition, potent self-protection from GBM and the presence of an immunosuppressive tumour environment comprised of Treg cells and marrow-derived stem cells (MDSCs) that produce IL-10 and TGF-β1 reduces the killing effects of DC-based vaccines on tumour cells.